The Food and Drug Administration on Friday granted emergency use authorization for the vaccine developed by Pfizer and BioNTech based on data showing it was 95% effective. CDC Director Dr. Robert Redfield signed off on the vaccine Saturday night, allowing inoculations to officially move forward for people ages 16 or older.